New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
New drug combinations raise hopes of effective, locally administered snakebite treatment

New drug combinations raise hopes of effective, locally administered snakebite treatment

by Lancaster UniversityCredit: Pixabay/CC0 Public DomainNew drug combinations could protect snakebite victims from the devastating, life-changing injuries caused by toxic venom, suggests research
Breakthroughs January 26,2024
New drug combinations raise hopes of effective, locally administered snakebite treatment

New drug combinations raise hopes of effective, locally administered snakebite treatment

by Lancaster UniversityCredit: Pixabay/CC0 Public DomainNew drug combinations could protect snakebite victims from the devastating, life-changing injuries caused by toxic venom, suggests research
Breakthroughs January 26,2024
Antimicrobial resistance now hits lower-income countries the hardest, but superbugs are a global threat

Antimicrobial resistance now hits lower-income countries the hardest, but superbugs are a global threat

by Laura Domínguez,The ConversationMicroscopic view of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. Credit: NIAID,CC BYAntimicrobial resistance (AMR) is one of the World He
Breakthroughs January 26,2024
Antimicrobial resistance now hits lower-income countries the hardest, but superbugs are a global threat

Antimicrobial resistance now hits lower-income countries the hardest, but superbugs are a global threat

by Laura Domínguez,The ConversationMicroscopic view of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. Credit: NIAID,CC BYAntimicrobial resistance (AMR) is one of the World He
Breakthroughs January 26,2024
EU watchdog backs anti-bilharzia parasite treatment for kids

EU watchdog backs anti-bilharzia parasite treatment for kids

Credit: Pixabay/CC0 Public DomainThe world's first medicine formulated to treat a damaging tropical parasite infection in preschool children received the green light Friday from Europe's drug
Breakthroughs January 26,2024
EU watchdog backs anti-bilharzia parasite treatment for kids

EU watchdog backs anti-bilharzia parasite treatment for kids

Credit: Pixabay/CC0 Public DomainThe world's first medicine formulated to treat a damaging tropical parasite infection in preschool children received the green light Friday from Europe's drug
Breakthroughs January 26,2024
Epilepsy drug shows promise in slowing joint degeneration in osteoarthritis

Epilepsy drug shows promise in slowing joint degeneration in osteoarthritis

by Yale Universitya, Safranin O and Fast Green-stained sections of knee joints of mice with the indicated genotype (n = 8). Scale bar, 50 µm.b–e, OARSI score (b), osteophyte development (c)
Breakthroughs January 26,2024
Epilepsy drug shows promise in slowing joint degeneration in osteoarthritis

Epilepsy drug shows promise in slowing joint degeneration in osteoarthritis

by Yale Universitya, Safranin O and Fast Green-stained sections of knee joints of mice with the indicated genotype (n = 8). Scale bar, 50 µm.b–e, OARSI score (b), osteophyte development (c)
Breakthroughs January 26,2024
Patients with common form of acute myeloid leukemia report better quality of life when treated with quizartinib

Patients with common form of acute myeloid leukemia report better quality of life when treated with quizartinib

byUniversity of Miami Leonard M. Miller School of MedicineAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainIn a study led by researchers at Sylvester Comprehensive Cancer Cente
Breakthroughs January 26,2024
Patients with common form of acute myeloid leukemia report better quality of life when treated with quizartinib

Patients with common form of acute myeloid leukemia report better quality of life when treated with quizartinib

byUniversity of Miami Leonard M. Miller School of MedicineAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainIn a study led by researchers at Sylvester Comprehensive Cancer Cente
Breakthroughs January 26,2024
ASH: Daratumumab beneficial for patients with multiple myeloma

ASH: Daratumumab beneficial for patients with multiple myeloma

by Elana GotkineFor transplantation-eligible patients with newly diagnosed multiple myeloma, the addition of subcutaneous daratumumab combined with bortezomib, lenalidomide, and dexamethasone inductio
Breakthroughs January 26,2024
ASH: Daratumumab beneficial for patients with multiple myeloma

ASH: Daratumumab beneficial for patients with multiple myeloma

by Elana GotkineFor transplantation-eligible patients with newly diagnosed multiple myeloma, the addition of subcutaneous daratumumab combined with bortezomib, lenalidomide, and dexamethasone inductio
Breakthroughs January 26,2024
Study suggests key to antipsychotic-drug–induced obesity

Study suggests key to antipsychotic-drug–induced obesity

by UTSouthwestern Medical CenterEffect of risperidone and risperidone + LepAb on body weight, food intake, and glucose tolerance. Female mice (n = 9) were placed on an HFD alone (Ctrl) or a
Breakthroughs January 26,2024
Study suggests key to antipsychotic-drug–induced obesity

Study suggests key to antipsychotic-drug–induced obesity

by UTSouthwestern Medical CenterEffect of risperidone and risperidone + LepAb on body weight, food intake, and glucose tolerance. Female mice (n = 9) were placed on an HFD alone (Ctrl) or a
Breakthroughs January 26,2024
Knowing how clinicians make real-world decisions about drug-drug interactions can improve patient safety

Knowing how clinicians make real-world decisions about drug-drug interactions can improve patient safety

by Regenstrief InstituteDescriptive model of clinicians’ DDI decision-making process. This figure shows the coding tree developed during the inductive qualitative analysis, with primary themes sh
Breakthroughs January 26,2024
Knowing how clinicians make real-world decisions about drug-drug interactions can improve patient safety

Knowing how clinicians make real-world decisions about drug-drug interactions can improve patient safety

by Regenstrief InstituteDescriptive model of clinicians’ DDI decision-making process. This figure shows the coding tree developed during the inductive qualitative analysis, with primary themes sh
Breakthroughs January 26,2024
Scientists find a 'scarcode' common across damaged organs

Scientists find a 'scarcode' common across damaged organs

byDuke-NUS Medical SchoolSPP1+macrophages are increased during fibrotic disease across human tissues. (A–F) Uniform Manifold Approximation and Projection (UMAP) dimensionality reduction of
World medicine January 26,2024
Scientists find a 'scarcode' common across damaged organs

Scientists find a 'scarcode' common across damaged organs

byDuke-NUS Medical SchoolSPP1+macrophages are increased during fibrotic disease across human tissues. (A–F) Uniform Manifold Approximation and Projection (UMAP) dimensionality reduction of
World medicine January 26,2024
Use of anticoagulant drug after aortic valve replacement lowers mortality risk, study finds

Use of anticoagulant drug after aortic valve replacement lowers mortality risk, study finds

by ByJay Furst,Mayo ClinicGraphical abstract. Credit:Mayo Clinic Proceedings(2023). DOI: 10.1016/j.mayocp.2023.08.012Patients who received the anticoagulant drug warfarin after biopr
Breakthroughs January 26,2024
Use of anticoagulant drug after aortic valve replacement lowers mortality risk, study finds

Use of anticoagulant drug after aortic valve replacement lowers mortality risk, study finds

by ByJay Furst,Mayo ClinicGraphical abstract. Credit:Mayo Clinic Proceedings(2023). DOI: 10.1016/j.mayocp.2023.08.012Patients who received the anticoagulant drug warfarin after biopr
Breakthroughs January 26,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com